George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here.
I can't help but feel there's market sentiment that there could be a curve ball from the Government announcement and AVCT going for that tender, hence the support at this SP (after reading the RNS this morning I honestly thought we'd see 90p today as there's little left now for short term PIs - but I didn't account for this Govt announcement today). We'll likely see a further rise as we approach 15:30.
As I'm fortunate enough to have an average well below 100 here I further derisked after reading today's RNS and I'm now here solely for the AVA6000 cancer treatment. If BAMS or even a nasal swab LFT can help pay for that then all the better, but I'm happy to sit longer term with a smaller investment here now. The timing of that 'house purchase' from AS stinks, and frankly when coupled with the leak of the placing to the traders it just doesn't sit well with me about how this company is being ran.
Defence budget increases are a way for governments to create tens of thousands of jobs - and seeing as tens of thousands will be lost because of Covid it gives the Government a platform to say "There are plenty of jobs out there for those who want them" - despite the fact no-one is quite sure how Tony - a stage hand at the Apollo theatre - is quite going to fit in building a new destroyer.
It also appeals to those Daily Mail readers in my generation who feel Britain should still be some kind of superpower - and it's those the Tories need to try and appease as their leafy homes and pensions are about to be targetted to begin repaying this immense debt Covid has caused.
Agreed. Definitely not AVCT. Heathrow didn’t test AVCT - they used two PCR tests and the Mologic saliva test.
https://www.independent.co.uk/news/health/coronavirus-test-heathrow-airport-travel-trial-quarantine-countries-screen-a9694981.html
Government are concerned about people “gaming” the system so any test which negates the requirement for quarantine or shortens that requirement will be administered by a professional and ID will be required.
Of course, once AVCT tests are available in vast quantities this may well change.
I assume they’re referring to this article:
https://www.dailymail.co.uk/news/article-8857205/Heathrow-staff-offer-80-pre-flight-coronavirus-tests.html
It’s not AVCT being used at Heathrow, though.
A viable, scaleable vaccine being produced is when the boat is officially 'missed'.
Even watching Trump bang on about the Abbott test yesterday, they still only have 150m of them. My first thought was 'Ok, and what about next week?'. The sheer scale of global testing that is required is staggering, and there's plenty of room for multiple players.
That being said, I think AVCT were either (best case) naive or (worst case) deliberately misleading when they gave some of those time scales earlier in the summer. This has led to a significant rumbling of disgruntlement that we've now got to October with no product when others (like NCYT) are announcing hundreds of millions of pounds in Government contracts for their ready-to-market products.
The reason I have held my position in this share is because I believe they will bring a game changing LFT to market and the money generated will be limited simply by their manufacturing capacity - but moreover they will play a significant part in bringing the UK (and quite possibly the world) back to some degree of normality.
BUT - I'm able to do this because I know they have their cancer treatments as a catch-all should this LFT go up in smoke. Being older I'm somewhat more risk averse than I was in my younger days and I know the chances of me losing money here are incredibly slim - it's just a couple of years for the return if I have to wait for the chemo/cancer returns vs a shorter term return on the LFT. This is why I came out of ODX after trebling my money - there's little to fall back on over there. At least here there's a very comfy looking safety net under us.
So personally I'm not concerned with missing the boat, as I know there are plenty of other boats coming along eventually - and I'm fortunate that I'm not in any rush to get off the beach.
Timster, that's helpful. I was also under the impression Mologic were in early stages but to have prototypes being used at Heathrow was a serious surprise for me. That's why I was wondering if they'd had some kind of government fast track funding.
There was a lot of talk on this board of "Show me another ten minute, saliva based, antigen LFT test". Well clearly there are now two. So I'm just curious if there are any results articles or otherwise which indicate AVCT.
The RNS relating to increase in manufacuturing capacity for AVCT with Abingdon Health yesterday certainly supports the argument that AVCT are ready to go, but I'm just curious about this Mologic test.
PL75 - This occured to me, but the Mologic press release about the Heathrow trials had this text:
CONDOR is working to accelerate the real-world use of COVID-19 diagnostics and their findings will help to identify the most accurate testing methods. Results of the study are being sent to Department for Health and Social Care to support the decision making process.
So I wasn't sure if they were also somehow involved.
I have done a fair amount of research on this and I can't find a definitve answer.
Without being screamed at by lunatics for 'deramping', would anyone be able to point me to any articles which indicate that the saliva based tests being referred to by the Government are AVCT, and not Mologic? From recent media reports about the Heathrow trials done by Mologic, they have active prototypes of a 10 minute, saliva based, LFT, antigen test that is currently being submitted to the government for review (based on their results from the Heathrow testing, done alongside Geneme and I-Abra.
I'm curious if anything singles out AVCT over Mologic with regard to the Government contracts?
The Mologic test gives results in ten minutes and doesn’t need a lab, according to their announcement about their trials on staff at Heathrow airport.
Has anything changed in the last week or two? Other than anticipation and a little bit of FOMO driving up the SP and day traders and MMs driving it back down a bit, I don't think so.
A couple of months ago my thoughts were that AVCT were going to bring a test to market to turn around the economy and get things moving again, and they were the only company capable of doing so in the timescales they were quoting. Well, I still believe the first part, though the timescales have been pushed back and there are now definitely other types of testing that will also be on the table - however that's offset by the sheer scale of the size of the market that has become apparent.
It doesn't really matter if some plug in LAMP test becomes the at home kit of choice, because it's still not fast enough to work effectively in schools, airports, cruise ships, etc. For that, you need AVCT's test.
Frankly, if AVCT didn't manage to get any of the home test market and just signed deals with transport hubs and schools it would send this soaring. Testing is going to become part and parcel of our lives for the next 12 months at least - and AVCT is the only test that makes sense for certain markets.
A 30p swing either way only matters if you're day trading. The amount of news in the pipeline is immense - so the only reason to sell is if you're trading the stock, or if you believe that after all this and all the technical seminars we've seen the AVCT tests aren't viable.
I certainly think that would be the case, CO. I was just surprised to see the media picking up on this plug in device - though perhaps that was due to him unpacking it in more detail, as you say.
I appreciate your posts.
And that's a very fair point. However when it comes to my money and investments I can look past my aversion to mainstream media. I just found it interesting they had focused on that LAMP tech in detail. Both tabloids who ran the story did the same thing.
PL - This is my point. The media have not said a ten minute LFD. They’ve reported on a one hour plug in device.
See The Sun article here: https://www.thesun.co.uk/news/12457795/coronavirus-test-results-minutes-approved-weeks/
I’m not saying Avacta isn’t the test - I’m saying the media have reported a different one.
Spike - I’m certainly not saying the Avacta test isn’t part of what the Professor was saying. All I’m highlighting is that the mainstream media seem to have focused on a different product. I’m not even sure which company it could be - Oxford Nano perhaps - who aren’t listed.
There is space in this market for multiple tests. What about areas without access to electrics? What about places where electrical items come with additional issues like requiring PAT testing? The Avacta test certainly seem to make more sense at airports, etc.
However, people raving here how the professor couldn’t possibly be referring to another test are incorrect. And the media has focused on something different.
I'm not deramping. I'm invested here.
But both the Sun articles and Daily Mail articles on the interview have detailed the LAMP plug in technology.
The interview mentions a plug in Antigen test being the one in which we have a basket of them in the bathroom - and it's the isothermal amplification tech (LAMP) that the media are reporting on.
The lack of a drop despite no news this morning certainly does feel like there's significant money starting to come in now as the endgame nears.
Of course, we could still see a MM shake early afternoon but it does appear that this share has finally found its climbing boots.
Talk of £20 is a dream, I feel. Given the myriad of opportunities presenting themselves I fully believe this will be acquired by Big Pharma sooner rather than later. If it gets to £6 before that happens I'll be very surprised.
Pleased, of course. But surprised.
You take your chances. This may well have a morning dip if we get no news after hours or at 7am.
If we do, this SP will be a distant memory.
Potentially if you wait you might get it 15p cheaper than the current SP if you time it right. If the RNS comes, you MIGHT be able to buy some at some point tomorrow - the price, however, will be well above the current.